Inhibiting HIV Fusion with a β-Peptide Foldamer

Publisher Website
Google Scholar
Abstract
Linear peptides derived from the HIV gp41 C-terminus (C-peptides), such as the 36-residue Fuzeon, are potent HIV fusion inhibitors. These molecules bind to the N-peptide region of gp41 and inhibit an intramolecular protein−protein interaction that powers fusion of the viral and host cell membranes. The N-peptide region contains a surface pocket that is occupied in the post-fusion state by three α-helical residues found near the gp41 C-terminus: Trp628, Trp631, and Ile635the WWI epitope. Here, we describe a set of β3-decapeptides (βWWI-1−4) in which the WWI epitope is presented on one face of a short 14-helix stabilized by macrodipole neutralization and side chain−side chain salt bridges. βWWI-1−4 bind in vitro to IZN17, a validated gp41 model, and inhibit syncytia formation in cell culture. Molecules lacking a complete WWI functional epitope neither bind IZN17 nor inhibit syncytia formation. These results provide evidence that short β-peptide 14-helices can inhibit an intramolecular protein−protein interaction in vivo. Molecules related to βWWI-1−4 could represent starting points for the development of highly potent inhibitors or antigens effective against HIV or other viruses, including SARS, Ebola, HRSV, and influenza, that employ common fusion mechanisms.

This publication has 59 references indexed in Scilit: